Supplementation while pregnant and psychotic – 20 percent Omega-3, 6 percent Vitamin D – June 2016

Supplement use by women during pregnancy: data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics.

Arch Womens Ment Health. 2016 Jun;19(3):437-41. doi: 10.1007/s00737-015-0586-0. Epub 2015 Oct 16.
Freeman MP1, Sosinsky AZ2, Moustafa D2, Viguera AC2,3, Cohen LS2.

• 1 Center for Women's Mental Health, Perinatal and Reproductive Psychiatry Program, Massachusetts General Hospital, 185 Cambridge Street, Suite 2200, Boston, MA, 02114, USA. mfreeman at partners.org.
• 2 Center for Women's Mental Health, Perinatal and Reproductive Psychiatry Program, Massachusetts General Hospital, 185 Cambridge Street, Suite 2200, Boston, MA, 02114, USA.
• 3 Cleveland Clinic, Cleveland Clinic Neurological Institute, Cleveland, OH, USA.

 Download the PDF from VitaminDWiki

Women of reproductive age commonly use integrative treatments. However, the reproductive safety for most complementary products lacks systematic study. We aimed to study the use of supplements by women in a prospective pregnancy registry. The Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics was established to evaluate the reproductive safety of atypical antipsychotics. Exposed and control participants were systematically queried about the use of vitamins and supplements.

Slightly greater than half (53.2 %) of the participants eligible for analysis (N = 534) were using at least one vitamin or supplement at the time of enrollment, not including prenatal vitamins or folic acid.
The most common supplements used were omega-3 fatty acids (38.0 %), vitamin D (11.0 %), calcium (8.2 %), and iron (4.7 %). Probiotics and melatonin were used by 2.6 and 0.9 %, respectively. In this prospective pregnancy registry, we found that over half of the participants were taking supplements or vitamins other than prenatal vitamins and folic acid. These findings underscore the need for active query on the part of health care providers about the use of supplements during pregnancy, and the need to obtain rigorous reproductive safety and efficacy data for supplements used by pregnant women and reproductive aged women.

PMID: 26472040 DOI: 10.1007/s00737-015-0586-0

From PDF

Bipolar disorder	54 %
Depression	20 %
Anxiety	9 %